We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tristel Plc | LSE:TSTL | London | Ordinary Share | GB00B07RVT99 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
15.00 | 3.23% | 480.00 | 460.00 | 480.00 | 470.00 | 465.00 | 465.00 | 33,518 | 16:35:01 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Med, Dental, Hosp Eq-whsl | 36.01M | 4.46M | 0.0941 | 49.95 | 222.78M |
Date | Subject | Author | Discuss |
---|---|---|---|
12/8/2023 11:55 | An American story ... Tristel North AmericaTristel North America We are thrilled to have participated in AVA's podcast: "High-Level Disinfection of Ultrasound Probes for Vascular Access".🎙 Listen in as we talk about ultrasound probe decontamination and how Tristel Duo and Tristel ULT can provide you with a solution. 🔗 | piedro | |
27/7/2023 16:58 | Excellent, quirky presentation. Anybody learn anything new? apad | apad | |
27/7/2023 14:14 | Open day recording ... | piedro | |
25/7/2023 16:43 | Hi Peter Any comment questions on the new Indian strategy | best1467 | |
25/7/2023 15:39 | Very interesting and positive visit to the open day. Lots more growth to come. | peter27 | |
25/7/2023 14:21 | Presentation now available | piedro | |
25/7/2023 09:02 | Whilst waiting for the presentation, this is an interesting read ... Parker’s High-Level Disinfectant Foam Receives FDA de novo Clearance Jul 19, 2023 Tori Whitacre Martonicz | piedro | |
25/7/2023 07:20 | Positive trading update.It will be interesting to find out when and by how much the top line will increase with the approval in US. | paulisi | |
20/7/2023 17:33 | I asked about this in the Q&A that followed the June presentation at the time that FDA approval was obtained. The company said that it had been advised by the FDA that future applications for different products would not have to follow the de novo route which was required for Tristel ULT and that, accordingly, the approval process should be considerably shorter for those products. It also opens up the LatAm market, as FDA approval is apparently pretty much a prerequisite. | james188 | |
20/7/2023 16:50 | It's an amazingly open list. Worth checking with Paton's analysis. I've been waiting a long time for the first FDA approval. I can't help but think that the follow-up approvals must be faster. apad | apad | |
20/7/2023 15:54 | Cheers James, I'll have a look. | melton john | |
20/7/2023 14:30 | Melton John, If you have not already done so, you should take a look at the June 2023 North American Business plan which is in the Investor section of the website (run by Wallbrook). It contains a fairly detailed timetable for approvals and product launch. We may also learn more at the Open Day next week for which Piedro has just posted details. | james188 | |
20/7/2023 14:11 | A reminder ... Tristel PLC 12 July 2023 Shareholder Open Day - And Notice of Trading Update Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that it will hold an Open Day for shareholders at the Company's headquarters in Snailwell, Cambridgeshire on Tuesday 25 July 2023 from 11am to 2pm. The Company will also provide an update on trading for the year ended 30 June 2023 on that date. The day will provide an opportunity for shareholders to meet the Senior Management team, take a tour of the facility and familiarise themselves with the Company's products. Availability is limited so please contact Walbrook PR via tristel@walbrookpr.c For those that are unable to make it in person, a recording of the presentation will be made available on the Company's website, shortly after the event here: Questions can be pre-submitted in advanced of the meeting via tristel@walbrookpr.c | piedro | |
20/7/2023 11:23 | There's a series of follow-up approvals for different applications and products in the offing, MJ. Well described in the results. Given the length of time it has taken for the first one we may get impatient or maybe there will be acceleration. apad | apad | |
20/7/2023 11:02 | How is the EPA approval process going, Chlorox seem to be the market leader in USA with plain old bleach, that's a much bigger market I would have thought. | melton john | |
17/7/2023 17:54 | TSTL now less than it was pre the announcement of the FDA approval. Surprising fall. apad | apad | |
24/6/2023 09:09 | ParkerLabs@ParkerLab Introducing Tristel ULT a high-level disinfectant foam for reprocessing ultrasound probes. Tristel ULT will make its US debut at the annual meeting of the Association for Professionals in Infection Control and Epidemiology (@APIC), June 26–28, in #Orlando. @TristelGlobal | piedro | |
09/6/2023 10:47 | . wrong thread | football | |
05/6/2023 21:29 | Currently in negotiations with a new partner the original partner was disappointing.India is a market where Indian companies mainly succeed so a royalty based deal maybe an option | best1467 | |
05/6/2023 16:27 | Piedro, I think that it was partly price and partly the inability to meet with the two selected partners due to COVID restrictions. I don’t believe that Tristel has given up on India. On opportunities, I meant to add that the surface disinfection business is still at a very early stage. I see that they are not planning to do much with it on the US for the next few years (finncap note issued today). | james188 | |
05/6/2023 16:18 | james188 "There are lots of places with decent opportunities that they have barely scratched. India and South America, for example." If I remember rightly, there was a problem with India over the price. That would no doubt be the same in South America where 'Bleach' is the cheapest option. AIMHO, BWDIK. - we may be able to ask at the webinar | piedro | |
05/6/2023 16:07 | Tristel North America@TristelAmeri May 23 Welcome to the Tristel North America Page, created to keep you up to date with our activities in the USA and Canada: news and events, product launches and relevant scientific information.🌎 We're a little new here, but we're excited to share everything that we do with you!📢 | piedro | |
05/6/2023 15:42 | Added ENQ today | blackhorse23 | |
05/6/2023 12:29 | There are lots of places with decent opportunities that they have barely scratched. India and South America, for example. | james188 | |
05/6/2023 12:10 | Hallelujah - not sure where the growth is once US is up and running though... | paulisi |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions